Stock Research for TEVA

TEVA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

TEVA Stock Chart & Research Data

The TEVA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TEVA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


TEVA Due diligence Resources & Stock Charts

The TEVA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TEVA Detailed Price Forecast - CNN Money CNN View TEVA Detailed Summary - Google Finance
Yahoo View TEVA Detailed Summary - Yahoo! Finance Zacks View TEVA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View TEVA Trends & Analysis - Trade-Ideas Barrons View TEVA Major Holders - Barrons
NASDAQ View TEVA Call Transcripts - NASDAQ Seeking View TEVA Breaking News & Analysis - Seeking Alpha
Spotlight View TEVA Annual Report - CompanySpotlight.com OTC Report View TEVA OTC Short Report - OTCShortReport.com
TradeKing View TEVA Fundamentals - TradeKing Charts View TEVA SEC Filings - Bar Chart
WSJ View Historical Prices for TEVA - The WSJ Morningstar View Performance/Total Return for TEVA - Morningstar
MarketWatch View the Analyst Estimates for TEVA - MarketWatch CNBC View the Earnings History for TEVA - CNBC
StockMarketWatch View the TEVA Earnings - StockMarketWatch MacroAxis View TEVA Buy or Sell Recommendations - MacroAxis
Bullish View the TEVA Bullish Patterns - American Bulls Short Pains View TEVA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View TEVA Stock Mentions - StockTwits PennyStocks View TEVA Stock Mentions - PennyStockTweets
Twitter View TEVA Stock Mentions - Twitter Invest Hub View TEVA Investment Forum News - Investor Hub
Yahoo View TEVA Stock Mentions - Yahoo! Message Board Seeking Alpha View TEVA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for TEVA - SECform4.com Insider Cow View Insider Transactions for TEVA - Insider Cow
CNBC View TEVA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TEVA - OTC Markets
Yahoo View Insider Transactions for TEVA - Yahoo! Finance NASDAQ View Institutional Holdings for TEVA - NASDAQ


Stock Charts

FinViz View TEVA Stock Insight & Charts - FinViz.com StockCharts View TEVA Investment Charts - StockCharts.com
BarChart View TEVA Stock Overview & Charts - BarChart Trading View View TEVA User Generated Charts - Trading View




Latest Financial News for TEVA


[$$] Lilly Approval to Spur Migraine-Prevention Market in Europe
Posted on Friday September 21, 2018

& Co.’s (LLY) preventive migraine drug galcanezumab has received a positive marketing recommendation from the European Medicines Agency, the company and the regulator said separately on Friday, opening the door to competition in Europe. The approval matters because the drug is one of a new class of compounds that inhibit the activity of a molecule involved in migraine attacks, for which there is currently no cure. Ltd. (TEVA) also received approval from the Food and Drug Administration for its own fremanezumab, after months of delays had weighed on investor sentiment.


FDA chief: Looking to regulate nicotine in cigarettes
Posted on Thursday September 20, 2018

U.S. FDA Commissioner Scott Gottlieb, in a wide-ranging interview, said they are looking to regulate nicotine in cigarettes in order to migrate smokers to modified risk products.


Teva Wins Approval From FDA for Blockbuster Migraine Drug
Posted on Tuesday September 18, 2018

Prospects are looking brighter for Teva Pharmaceuticals Industries Limited (NYSE:TEVA). The company won a pair of FDA approvals in September. The big news here is the FDA approving its migraine treatment.


Teva finds big tenant to take over lease at its OP headquarters
Posted on Tuesday September 18, 2018

Teva Neuroscience Inc. plans to sublease its Overland Park headquarters to a fast-growing health IT company.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.